Phase 2 trials evaluate safety and initial efficacy in a larger population with the target disease. Which phase is this?

Phase 2 trials evaluate safety and initial efficacy in a larger population with the target disease. Which phase is this?

• A. Phase 1
• B. Phase 2
• C. Phase 3
• D. Phase 4

Answer: (B)

In the middle stage of clinical development, researchers test the drug in patients who actually have the disease to see whether it shows initial therapeutic effects while continuing to monitor safety and refine dosing. This phase follows the early safety and dose-finding work and precedes the large, definitive efficacy trials. It’s designed to provide a better sense of whether the drug works in the target population and to gather more safety data before moving on to broader testing. After this stage, trials typically proceed to large-scale studies to confirm efficacy, and later phases monitor long-term safety after approval.

In the middle stage of clinical development, researchers test the drug in patients who actually have the disease to see whether it shows initial therapeutic effects while continuing to monitor safety and refine dosing. This phase follows the early safety and dose-finding work and precedes the large, definitive efficacy trials. It’s designed to provide a better sense of whether the drug works in the target population and to gather more safety data before moving on to broader testing. After this stage, trials typically proceed to large-scale studies to confirm efficacy, and later phases monitor long-term safety after approval.